IMMUNE Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute
May 23, 2012 10:24 ET
|
IMMUNE Pharmaceuticals
HERZLIYA and REHOVOT, Israel, May 23, 2012 (GLOBE NEWSWIRE) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibodies, and Yeda, the technology transfer company of the...
Myrtle Potter & Company is Retained by IMMUNE Pharmaceuticals as Business Development Advisor for NanomAb Drug Conjugates Portfolio
April 26, 2012 08:00 ET
|
IMMUNE Pharmaceuticals
SAN JOSE, Calif. and HERZLIYA, Israel, April 26, 2012 (GLOBE NEWSWIRE) -- Myrtle Potter & Company announced today that it has been retained by IMMUNE Pharmaceuticals as an advisor for their...
IMMUNE Pharmaceuticals Granted US$1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel
January 30, 2012 08:30 ET
|
IMMUNE Pharmaceuticals
HERZLIYA, Israel and NEW YORK, Jan. 30, 2012 (GLOBE NEWSWIRE) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibody based therapeutics for the treatment of...